Related references
Note: Only part of the references are listed.Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics
Marc Hafner et al.
NATURE BIOTECHNOLOGY (2017)
GRcalculator: an online tool for calculating and mining dose-response data
Nicholas A. Clark et al.
BMC CANCER (2017)
Reproducible pharmacogenomic profiling of cancer cell line panels
Peter M. Haverty et al.
NATURE (2016)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
Inconsistency in large pharmacogenomic studies
Benjamin Haibe-Kains et al.
NATURE (2013)
Metrics other than potency reveal systematic variation in responses to cancer drugs
Mohammad Fallahi-Sichani et al.
NATURE CHEMICAL BIOLOGY (2013)
A Simple High-Content Cell Cycle Assay Reveals Frequent Discrepancies between Cell Number and ATP and MTS Proliferation Assays
Grace Ka Yan Chan et al.
PLOS ONE (2013)
Modeling precision treatment of breast cancer
Anneleen Daemen et al.
GENOME BIOLOGY (2013)
Subtype and pathway specific responses to anticancer compounds in breast cancer
Laura M. Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047
Wen-Lin Kuo et al.
BMC MEDICINE (2009)
Share Paper
